New clinical advances in MDS risk categorization
Автор: MDS Hub
Загружено: 2022-03-28
Просмотров: 115
Описание:
The MDS Hub was pleased to speak to Theo de Witte, Radboudumc, Nijmegen, NL. We asked, What are the new clinical advances in MDS risk categorization?
In this video, de Witte discusses the current landscape of diagnosis and prognosis for patients with MDS, alongside the current drugs available, including lenalidomide and hypomethylating agents (HMAs). He also highlights how mutations and variant allele frequency (VAF) can affect patient outcome.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: